TrialBMJ open2017

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of

Matti Lehtinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.